Muse

Muse is a brand name of alprostadil, approved by the FDA in the following formulation(s):

MUSE (alprostadil - suppository; urethral)

• 
  Manufacturer: MEDA PHARMS
  
  Approval date: November 19, 1996
  
  Strength(s): 0.125MG, 0.25MG, 0.5MG, 1MG ^[RLD]

Has a generic version of Muse been approved?

No. There is currently no therapeutically equivalent version of Muse available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Muse. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Dosage and inserter for treatment of erectile dysfunction
  Patent 5,474,535
  Issued: December 12, 1995
  Inventor(s): Place; Virgil A. & Gale; Robert M. & Berggren; Randall G.
  Assignee(s): Vivus, Inc.
  Erectile dysfunction, particularly impotence, priapism and Peyronie's disease is treated by the transurethral administration of a therapeutically effective agent. The agents are administered to the urethra by means of a penile insert (40) having a shaft with a deformable distal end which forms a dose receiving cavity when an internal piston is retracted relative to the shaft.
  
  Patent expiration dates:
  
  
  • December 12, 2012
    
    ✓ 
    Patent use: TREATMENT OF ERECTILE DYSFUNCTION
  
  



• 
  Method and composition for treating erectile dysfunction
  Patent 5,886,039
  Issued: March 23, 1999
  Inventor(s): Kock; Nils G. & Lycke; Gerhard
  Lipophilic active substance composition and its use in a new method of treating erectile dysfunction by administration thereof, optionally together with a hydrophilic vehicle and optionally an antibacterial agent into the urethra.
  
  Patent expiration dates:
  
  
  • March 23, 2016
    
    ✓ 
    Patent use: TREATMENT OF ERECTILE DYSFUNCTION
    ✓ 
    Drug product
  
  

See also...

• Muse Suppository Consumer Information (Wolters Kluwer)
• Muse injectable and transurethral Consumer Information (Cerner Multum)
• Muse Advanced Consumer Information (Micromedex)
• Alprostadil Consumer Information (Wolters Kluwer)
• Alprostadil Suppository Consumer Information (Wolters Kluwer)
• Alprostadil injectable and transurethral Consumer Information (Cerner Multum)
• Muse Micro Advanced Consumer Information (Micromedex)
• Alprostadil Intraurethral, Intravenous, Intracavernosal Advanced Consumer Information (Micromedex)
• Alprostadil AHFS DI Monographs (ASHP)